Efficacy and Safety of Heme-Iron Polypeptide on Improvement of Anemia
|ClinicalTrials.gov Identifier: NCT01733979|
Recruitment Status : Unknown
Verified November 2012 by Soo-Wan Chae, Chonbuk National University Hospital.
Recruitment status was: Recruiting
First Posted : November 27, 2012
Last Update Posted : November 28, 2012
|Condition or disease||Intervention/treatment||Phase|
|Anemia||Dietary Supplement: Heme-Iron Polypeptide Dietary Supplement: Placebo Dietary Supplement: Heme-Iron Dietary Supplement: Organic Iron||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Study Start Date :||February 2012|
|Primary Completion Date :||February 2012|
|Estimated Study Completion Date :||December 2012|
|Experimental: Heme-Iron Polypeptide||
Dietary Supplement: Heme-Iron Polypeptide
Heme-Iron Polypeptide (1g/day)
|Placebo Comparator: Placebo||
Dietary Supplement: Placebo
|Active Comparator: Heme-Iron||
Dietary Supplement: Heme-Iron
|Active Comparator: Organic Iron||
Dietary Supplement: Organic Iron
Organic Iron (1g/day)
- Changes in hemoglobin [ Time Frame: 4 weeks ]Hemoglobin was measured in study visit 1(0 week) and visit 5(4 week).
- Changes in transferrin saturation [ Time Frame: 4 weeks ]Transferrin saturation was measured in study visit 1(0 week) and visit 5(4 week).
- Changes in serum iron [ Time Frame: 4 weeks ]Serum iron was measured in study visit 1(0 week) and visit 5(4 week).
- Changes in ferritin [ Time Frame: 4 weeks ]Ferritin was measured in study visit 1(0 week) and visit 5(4 week).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01733979
|Korea, Republic of|
|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital||Recruiting|
|Jeonju, Jeollabuk-do, Korea, Republic of, 560-822|
|Contact: Dal-Sik Kim, MD., PhD 82-63-250-1793 email@example.com|